Literature DB >> 17624820

Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies.

Gerald Friedland1, Anthony Harries, David Coetzee.   

Abstract

The many interactions between tuberculosis (TB) and human immunodeficiency virus (HIV) infection influence the design and implementation of programs to address the needs of patients living with or at risk for both diseases. Collaboration between national TB and HIV programs and some degree of integration of services at a local level have been advocated by the World Health Organization and other international bodies and are recognized as essential in areas where the 2 diseases are prevalent. However, in most settings, strategies to accomplish this are only beginning to reach the field where their impact will be made and the expectation of improving the outcome of both diseases realized. In this article, 3 such strategies, offering varying degrees of collaboration and integration, are described, 1 at a national level in Malawi and 2 at local sites in South Africa. These geographically and programmatically distinct experiences in TB/HIV service integration are instructive, illustrate common themes, and show that the strategy can be successful, but they also show that programmatic, medical, staffing, resource, and scale-up challenges remain. In addition, they indicate that, although broad program principles of TB/HIV service integration are essential, program designs and components may vary by country and even within countries, as a result of differing TB and HIV disease prevalences, resources, levels of expertise, and differences in program settings (urban vs. rural and/or primary vs. district vs. specialty site). Large national programs can successfully provide rapid, uniform and widespread change and implementation but also must negotiate the subtleties of intricacies of TB/HIV interactions, which confound a uniform "one size fits all" public health approach. Conversely, smaller demonstration projects, even with successful outcomes, must grapple with issues related to generalization of findings, wider implementation, and scale up, to benefit larger populations of those in need.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624820     DOI: 10.1086/518664

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward.

Authors:  A Kagee; R H Remien; A Berkman; S Hoffman; L Campos; L Swartz
Journal:  Glob Public Health       Date:  2011

2.  Antiretroviral treatment among co-infected tuberculosis patients in integrated and non-integrated facilities.

Authors:  T D Ledibane; S C Motlhanke; A Rose; W H Kruger; N R T Ledibane; M M Claassens
Journal:  Public Health Action       Date:  2015-06-21

Review 3.  Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics.

Authors:  Simon J Tsiouris; Neel R Gandhi; Wafaa M El-Sadr; Gerald Friedland
Journal:  MedGenMed       Date:  2007-09-25

4.  The emergence and effectiveness of global health networks: findings and future research.

Authors:  Jeremy Shiffman; Hans Peter Schmitz; David Berlan; Stephanie L Smith; Kathryn Quissell; Uwe Gneiting; David Pelletier
Journal:  Health Policy Plan       Date:  2016-04       Impact factor: 3.344

Review 5.  HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

Authors:  Salim S Abdool Karim; Gavin J Churchyard; Quarraisha Abdool Karim; Stephen D Lawn
Journal:  Lancet       Date:  2009-08-24       Impact factor: 79.321

Review 6.  Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community.

Authors:  Sheela Shenoi; Scott Heysell; Anthony Moll; Gerald Friedland
Journal:  Curr Opin Infect Dis       Date:  2009-02       Impact factor: 4.915

Review 7.  Extensively drug-resistant tuberculosis: a new face to an old pathogen.

Authors:  Sheela Shenoi; Gerald Friedland
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

Review 8.  Treatment Options for HIV-Associated Tuberculosis.

Authors:  Philip Chukwuka Onyebujoh; Isabela Ribeiro; Christopher Curtis Whalen
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

9.  Tuberculosis and HIV-Needed: A New Paradigm for the Control and Management of Linked Epidemics.

Authors:  Simon J Tsiouris; Neel R Gandhi; Wafaa M El-Sadr; Friedland Gerald
Journal:  J Int AIDS Soc       Date:  2007-09-25       Impact factor: 5.396

10.  The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa.

Authors:  Rubeshan Perumal; Nesri Padayatchi; Ellen Stiefvater
Journal:  BMC Public Health       Date:  2009-07-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.